We found the TP53 and ATM comutation in 37 of 1031 patients with NSCLC (3.6%) in the TCGA database15 and 52 of 2020 patients with NSCLC (2.6%) in the Geneplus database (eFigure 2 in the Supplement). Here, TP53 is linked to non-small cell lung carcinoma.